My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

Leqembi is the first FDA-approved drug shown to slow the progression of early-stage Alzheimer’s. Medi-Cal can cover Leqembi ...

Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...

California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...

Neurogen Biomarking will present novel data on at-home p-tau 217 testing for Alzheimer’s disease at the upcoming Alzheimer’s Association International Conference® (AAIC) in Toronto, Canada. Chief ...

However, some research suggests that poor sleep could raise your risk of Alzheimer’s. A study published in November found ...

Alzheimer's disease (AD) is a progressive neurocognitive disease that slowly erodes an individual's memory, judgment, cognition, learning, and, eventually, ability to function. It is the leading ...

Massive proteomics database links gene variant APOE 4 to chronic inflammation.

The report offers the first estimates of Alzheimer’s disease prevalence in the US at the county level. Researchers used data from thousands of individuals who participated in the Chicago Health ...

We appreciate the opportunity to address the comments by Yangfan Cheng and colleagues, and Sebastian Walsh and colleagues regarding our Article on long-term gantenerumab treatment in dominantly ...

Familial Alzheimer’s disease, which is very rare, is caused by gene mutations that run in your family and usually develops before age 65. Sporadic Alzheimer’s disease is more common.